The Supreme Court, preemption, and malpractice liability.
作者信息
Kesselheim Aaron S, Studdert David M
机构信息
Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women's Hospital, Harvard Medical School, Boston, USA.
出版信息
N Engl J Med. 2009 Feb 5;360(6):559-61. doi: 10.1056/NEJMp0809403.
PMID:19196672
Abstract
摘要
相似文献
1
The Supreme Court, preemption, and malpractice liability.
N Engl J Med. 2009 Feb 5;360(6):559-61. doi: 10.1056/NEJMp0809403.
2
Preemption and malpractice liability.
N Engl J Med. 2009 May 21;360(21):2257-8; author reply 2258. doi: 10.1056/NEJMc090478.
3
The federal preemption debate in pharmaceutical labeling product liability actions.
Tort Trial Insur Pract Law J. 2007 Fall;43(1):35-70.
4
Good law from tragic facts--Congress, the FDA, and preemption.
N Engl J Med. 2009 Sep 17;361(12):1206-11. doi: 10.1056/NEJMhle0902889.
5
6
The case for preemption of prescription drug failure-to-warn claims.
Food Drug Law J. 2007;62(2):399-422.
7
Pin the tail on the other donkey: allocating and avoiding injury losses after drug or device approval.
Food Drug Law J. 2007;62(3):559-72.
8
Legal Liability of Generic vs Brand Drug Manufacturers for Inadequate Product Labels.
JAMA. 2018 Aug 14;320(6):547-548. doi: 10.1001/jama.2018.8408.
9
A strike against preemption.
Nat Biotechnol. 2009 May;27(5):397. doi: 10.1038/nbt0509-397.
10
A defense of the learned intermediary doctrine.
Food Drug Law J. 2008;63(2):421-38.
Zotero 插件